Michael Ha Analyst Performance

Senior Research Analyst at Robert W. Baird

Michael Ha is a stock analyst at Robert W. Baird focused in the medical sector, covering 14 publicly traded companies. Over the past year, Michael Ha has issued 27 stock ratings, including buy, hold, and sell recommendations. While full access to Michael Ha's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Ha's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rating: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 27 Last 0 Years
Buy Recommendations: 30.77% 8 Buy Ratings
Companies Covered: 14 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	30.8%	8 ratings
Hold	65.4%	17 ratings
Sell	3.8%	1 ratings

Out of 26 total stock ratings issued by Michael Ha at Robert W. Baird, the majority (65.4%) have been Hold recommendations, followed by 30.8% Buy and 3.8% Sell.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NYSE	78.6% of companies on NYSE	11 companies
NASDAQ	21.4% of companies on NASDAQ	3 companies

Michael Ha, an analyst at Robert W. Baird, currently covers 14 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 13 companies	92.9%
	Finance 1 company	7.1%

Michael Ha of Robert W. Baird specializes in stock coverage within the Medical sector, with additional focus on Finance companies.

Coverage Industries

Industry	Percentage
MED - HMO 5 companies	35.7%
MED - HOSPITALS 3 companies	21.4%
MEDICAL SERVICES 3 companies	21.4%
INS - MULTI LINE 1 company	7.1%
MEDICAL INFO SYS 1 company	7.1%
MED - OUTP/HM CRE 1 company	7.1%

About Michael Ha

Michael Ha is a Baird Senior Research Analyst covering Managed Care and Healthcare Facilities. Prior to joining Baird in 2024, Michael worked as a Senior Equity Research Analyst covering Managed Care and Healthcare Facilities at Morgan Stanley. Michael’s experience also includes working as a Vice President – Equity Research covering Managed Care and Healthcare Facilities at both Cowen Inc. and J.P. Morgan and working in corporate finance and strategy at Agilon Health and Vantage Oncology. Early in his career, Michael worked as an Equity Research Associate at Wedbush Securities, as an Associate Portfolio Manager at Alliance Bernstein, and as a Foreign Exchange Analyst at Barclays Capital. Michael received BS in Finance from Rutgers University.

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
CI Cigna Group	8/14/2025	Set Price Target	$286.83	$372.00
UHS Universal Health Services	8/14/2025	Lower Price Target	$177.84	$203.00	Neutral
HCA HCA Healthcare	8/14/2025	Boost Price Target	$391.36	$423.00	Neutral
CI Cigna Group	8/14/2025	Boost Price Target	$288.38	$374.00	Outperform
CVS CVS Health	8/14/2025	Upgrade	$65.91	$82.00	Outperform
UNH UnitedHealth Group	7/31/2025	Reiterated Rating	$266.43	$198.00	Underperform
THC Tenet Healthcare	7/25/2025	Lower Price Target	$147.99	$167.00	Neutral
MOH Molina Healthcare	7/25/2025	Lower Price Target	$157.79	$179.00	Neutral
HUM Humana	7/25/2025	Lower Price Target	$229.48	$297.00	Neutral
ELV Elevance Health	7/25/2025	Lower Price Target	$280.28	$297.00	Neutral
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
CNC Centene	7/25/2025	Lower Price Target	$26.72	$28.00	Neutral
OSCR Oscar Health	7/25/2025	Reiterated Rating	$14.22	$14.00	Neutral
UNH UnitedHealth Group	6/11/2025	Downgrade	$303.89	$312.00	Neutral
UNH UnitedHealth Group	5/14/2025	Lower Price Target	$311.23	$356.00	Outperform
UNH UnitedHealth Group	4/29/2025	Lower Price Target	$420.04	$510.00	Outperform
CNC Centene	4/15/2025	Lower Price Target	$62.94	$69.00	Neutral
CI Cigna Group	4/15/2025	Lower Price Target	$328.71	$362.00	Outperform
ALHC Alignment Healthcare	4/15/2025	Boost Price Target	$19.13	$22.00	Outperform
UHS Universal Health Services	4/15/2025	Reiterated Rating	$178.88	$224.00	Neutral
THC Tenet Healthcare	4/15/2025	Reiterated Rating	$124.77	$137.00	Neutral
MOH Molina Healthcare	4/15/2025	Reiterated Rating	$348.92	$375.00	Neutral
HCA HCA Healthcare	4/15/2025	Reiterated Rating	$340.75	$336.00	Neutral
ELV Elevance Health	4/15/2025	Reiterated Rating	$441.02	$529.00	Neutral
PRVA Privia Health Group	4/15/2025	Boost Price Target	$24.05	$26.00	Outperform
HUM Humana	4/15/2025	Boost Price Target	$284.27	$300.00	Neutral
CVS CVS Health	4/15/2025	Boost Price Target	$69.15	$71.00	Neutral
ASTH Astrana Health	3/3/2025	Lower Price Target	$25.38	$50.00	Outperform

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.